StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the medical equipment provider’s stock.
Aethlon Medical Stock Up 1.4 %
Shares of Aethlon Medical stock opened at $0.38 on Wednesday. The stock has a market cap of $5.21 million, a PE ratio of -0.08 and a beta of 1.74. The business has a fifty day simple moving average of $0.41 and a 200-day simple moving average of $0.59. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last issued its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.10. During the same period last year, the business earned ($1.30) earnings per share. Analysts expect that Aethlon Medical will post -1.1 EPS for the current fiscal year.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Stories
- Five stocks we like better than Aethlon Medical
- What Are Dividend Contenders? Investing in Dividend Contenders
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Invest in the FAANG Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
